TABLE 4.

Synergistic interactions of antifungals assessed by ΣFICs derived from IC₅₀s obtained by visual readings

Candida strain	Antifungal combination	Visual median ΣFIC	No. of laboratories in agreement (%)
C. albicans 20464.007	AND-PSC	0.49	3 (37.5)
	CSP-MCF	0.44	4 (50.0)
	CSP-PSC	0.49	5 (62.5)
C. glabrata 20205.075	AMB-PSC	0.46	6 (75.0)
C. parapsilosis 20580.070	AMB-AND	0.38	7 (87.5)
	AMB-CSP	0.49	5 (62.5)
	AMB-PSC	0.50	3 (37.5)
	AND-PSC	0.50	6 (75.0)